Belvarafenib penetrates the BBB and shows potent antitumor activity in a murine melanoma brain metastasis model.

Saved in:
Bibliographic Details
Title: Belvarafenib penetrates the BBB and shows potent antitumor activity in a murine melanoma brain metastasis model.
Authors: Kim YY; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea., Park H; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea., Song T; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea., Choi K; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea., Dolton M; Genentech Inc, South San Francisco, CA, USA., Mao J; Genentech Inc, South San Francisco, CA, USA., Kim J; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea., Ahn YG; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea., Suh KH; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea., Kim YH; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea. yhkeem@hanmi.co.kr.
Source: Clinical & experimental metastasis [Clin Exp Metastasis] 2023 Apr; Vol. 40 (2), pp. 137-148. Date of Electronic Publication: 2023 Feb 10.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7276 (Electronic) Linking ISSN: 02620898 NLM ISO Abbreviation: Clin Exp Metastasis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1573-7276
DOI:10.1007/s10585-023-10198-7